Search research articles
Contact Us
Filters
Showing results (311-320 of 338) with videos related to
Page
of 34
Sort By:
Science Translational Medicine
|
March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2021
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W Ho, Igor L Gomes-Santos, Shuichi Aoki, et al.
Endoscopic Ultrasound
|
June 29, 2019
Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic cancer (PEACE): A study protocol
Adrian Sãftoiu, Manoop S Bhutani, Takao Itoi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Ebiomedicine
|
July 19, 2016
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
Kern Rei Chng, Sock Hoai Chan, Amanda Hui Qi Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients
Christopher G Willett, Yves Boucher, Dan G Duda, et al.
Nature Medicine
|
January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 338) with videos related to
Sort By:
Page
of 34
Science Translational Medicine
|
March 16, 2018
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio, Jennifer A Ligibel, Daniel T McManus, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2021
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W Ho, Igor L Gomes-Santos, Shuichi Aoki, et al.
Endoscopic Ultrasound
|
June 29, 2019
Changes in tumor vascularity depicted by contrast-enhanced EUS as a predictor of prognosis and treatment efficacy in patients with unresectable pancreatic cancer (PEACE): A study protocol
Adrian Sãftoiu, Manoop S Bhutani, Takao Itoi, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 17, 2024
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab
Ryan J Park, Milan Parikh, Leon Pappas, et al.
Ebiomedicine
|
July 19, 2016
Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma
Kern Rei Chng, Sock Hoai Chan, Amanda Hui Qi Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients
Christopher G Willett, Yves Boucher, Dan G Duda, et al.
Nature Medicine
|
January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Page
of 34